About Planet Fitness, Inc. (PLNT)

Planet Fitness Inc is a franchisor and operator of fitness centers in the United States. The company's reportable segments are Franchise, Corporate-owned stores, and Equipment.

PLNT trading today

PLNT has traded between $59.43 and $61.74 in the current session, a range of $2.31. The latest price of $61.11 sits in the middle of that range (73% of the way from low to high). It opened at $61.00, a gap down of 0.18% from the prior close of $61.11. The volume-weighted average price is $61.09, and the stock is trading above it. Traders often use VWAP as a gauge of whether buyers or sellers have had the better average entry today.

Where PLNT holders stand

StockMarketLoop's Market Position model estimates how the shares traded between 2026-08-12 and 2026-11-10 were bought. Its estimate of the average cost basis is $49.75; at $61.11 the stock trades 22.8% above that level. About 99.1% of those shares are estimated to be held at a profit at the current price. A high figure means most recent buyers are in the green, which can mean fewer trapped holders overhead, and also more people with gains who might sell. The densest nearby clusters of cost basis sit around $41.90 (support) and $61.19 (resistance). Roughly 70% of the estimated cost basis lies between $42.08 and $55.55, and 90% between $40.63 and $59.92.

This is a model estimate built from price and volume history, not a record of actual positions.

Latest PLNT coverage

• $PLNT Analyst Price Target: TD Cowen Raises to $61.00, Keeps Hold Rating Nov 8, 2026
  The archived PLNT provider entry names TD Cowen, a $61.00 target versus $54.00 previously, and a Hold rating. Its provider record date is 2026-11-08; the original research note…

How to read this page

Quote figures come from StockMarketLoop's market data feed and may be delayed; the timestamp in the summary above shows when they were observed. Company details come from public reference data. The cost-basis section is a statistical model, not a forecast. Nothing here is investment advice; see our financial disclaimer and editorial policy.